ArticleEuropean heart journal. Imaging methods and practice2026
Comparing transthoracic echocardiography, 2D and 4D flow cardiovascular magnetic resonance for quantitative valve assessment after percutaneous pulmonary valve implantation.
Article in European heart journal. Imaging methods and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: To compare transthoracic echocardiography (TTE), 2D and 4D flow cardiovascular magnetic resonance (CMR) for the evaluation of valve function and flow measurements after percutaneous pulmonary valve implantation (PPVI). Methods and results: In this multicentre exploratory observational study, 29 patients who underwent PPVI were planned for TTE and CMR with 2D and 4D flow measurements after PPVI. Peak velocity was measured with all techniques. Net and regurgitating flow measurements were measured with CMR distal to the transcatheter pulmonary valve (TPV). Median peak velocity of the TPV with TTE was 2.5 (2.0-3.1) m/s, with 2D flow CMR 2.3 (2.0-3.2) m/s, and with 4D flow 2.3 (2.0-3.0) m/s. There was a good correlation for the peak velocity of the TPV between TTE and 2D flow CMR ( Conclusion: TTE, 2D flow CMR, and 4D flow CMR are all feasible and reliable imaging techniques after PPVI, concordant in predominantly mild-to-moderate stenosis. These findings strengthen the use of 2D and 4D flow CMR as a tool for post-PPVI assessment, despite stent-induced artefacts, although reliability in more advanced valve dysfunction remains uncertain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.